Eli Lilly & Co. vs Natera, Inc.
LLY vs NTRA — side-by-side comparison from reported financials. LLY leads 5, NTRA leads 3 of 8 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Natera, Inc.
NTRA · Healthcare
$400.71+2.54%Strained
| Metric | LLY | NTRA |
|---|---|---|
| Price | $1 177.20 | $400.71 |
| Market cap | $1.05T | $57.8B |
| Revenue (TTM) | $79.7B | $2.71B |
| Revenue growth | +31.7% | +41.1% |
| Net margin | 33.5% | -7.1% |
| Free cash flow | $18.2B | $84.2M |
| Net cash (debt) | ($35.2B) | $1.02B |
| 1-year price return | +37.6% | +131.6% |
| P/E | 41.6 | — |
| P/E vs own history (cheap-side %) | 88% | — |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | -12% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 4 of 11 |
| Employees | 50,000 | 6,140 |
Full résumé-style profiles: LLY CV · NTRA CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.